Resmed CDI (ASX:RMD)
Health Care Equipment & Services
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
Resmed CDI (ASX:RMD) share price
Resmed CDI (ASX:RMD) share price news
ASX Growth Shares
Four Big Oversold Stocks with 6% Yields
Marcus Today does Technical Scans every day, and on 15 September 2023, they turned up four big stocks (five if you include Resmed CDI (ASX: RMD), seven including resources) that are interestingly oversold on weekly charts.
September 19, 2023
ASX Growth Shares
The Match Out: S&P/ASX 200 (INDEXASX:XJO) falls ahead of key US inflation data
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down +0.74% to 7153.90.
September 13, 2023
ASX Growth Shares
The Match Out: S&P/ASX 200 (INDEXASX:XJO) edges higher
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.20% to 7206.90.
September 12, 2023
ASX Growth Shares
Will weight-loss wonder Ozempic kill Resmed CDI (ASX:RMD) shares?
The Resmed CDI (ASX: RMD) share price was crushed after its Q4 2023 financial results. Is Resmed’s share price an allergic reaction to Ozempic, or something else?
August 29, 2023
ASX Growth Shares
Cochlear Ltd (ASX:COH) share price pops: our Cochlear thesis
The Cochlear Limited (ASX: COH) share price bounced dramatically higher this week following a bumper report. But is the Cochlear share price looking a little expensive? Stock Doctor’s Daniel Ortisi weighs in.
August 17, 2023
ASX Bank Shares
S&P/ASX 200 dips on healthcare, Mesoblast tanks on FDA queries
S&P/ASX 200 (ASX:XJO) managed a 0.2% gain on Friday, overcoming weakness in healthcare. Karoon Energy Ltd (ASX:KAR) share price rose 4.2%.
August 7, 2023
ASX Growth Shares
Why the ResMed (ASX:RMD) share price is down 11% today
ResMed CDI (ASX: RMD) shares are trading down about -11% in early trade to ~$30 per share after its 4Q23 result came in below consensus expectations.
August 4, 2023
ASX Growth Shares
Why the Resmed (ASX: RMD) share price is charging higher today
The Resmed CDI (ASX:RMD) share price bounced 6.5% higher today following the release of its Q3 results. Resmed and CSL Limited (ASX:CSL) seem good value relative to Cochlear Limited (ASX:COH).
May 1, 2023
ASX Growth Shares
2 ASX healthcare shares to buy for defensive earnings (one big, one small)
Resmed CDI (ASX:RMD) shares and the Monash IVF Group Ltd (ASX:MVF) share price look very tempting at these prices, writes Seneca’s Luke Laretive.
March 28, 2023